CTOs on the Move

WellDoc

www.welldoc.com

 
We`re making healthcare transformation personal. Driving down the cost of chronic conditions is going to take all of us. Welldoc is here to help with BlueStar, our in-app digital assistant for type 2 diabetes. Chronic with ease. Working together to redefine how engaging and personally transformative technology can be will lead to real change: starting and evolving habits, taking daily responsibility for our well-being, and moving outcomes and costs to a much more manageable place. Technology and teamwork. It`s time to make every moment, every action, every healthcare decision count.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.welldoc.com
  • 10221 Wincopin Circle Suite 150
    Columbia, MD USA 21044
  • Phone: 443.692.3100

Executives

Name Title Contact Details
Ken Brown
 Chief Information Security Officer Profile

Similar Companies

Hometeam

Headquartered in NYC, Hometeam empowers caregivers to deliver high-quality home care for older adults, a population in the US that`s growing at a rapid pace. Our custom technology enhances our delivery of care, but it`s our employees who make a tangible impact on people`s lives everyday. Whether you`re a Caregiver in the field or a Software Engineer in our corporate office, Hometeam provides employees the opportunity to elevate the standards of home care in America.

Palo Pinto General Hospital

Palo Pinto General Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Palo Pinto General Hospital is based in Mineral Wells, TX. You can find more information on Palo Pinto General Hospital at www.ppgh.com

IOS Foundation

IOS Foundation is a Chagrin Falls, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ashwood Retirement and Assisted

Ashwood Retirement and Assisted is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Savient

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA? (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy.